Unknown

Dataset Information

0

Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.


ABSTRACT: Effector CD8+ T cell function is impaired in systemic lupus erythematosus (SLE) and is associated with a compromised ability to fight infections. Signaling lymphocytic activation molecule family member 7 (SLAMF7) engagement has been shown to enhance natural killer cell degranulation. This study was undertaken to characterize the expression and function of SLAMF7 on CD8+ T cell subsets isolated from the peripheral blood of SLE patients and healthy subjects.CD8+ T cell subset distribution, SLAMF7 expression, and expression of cytolytic enzymes (perforin, granzyme A [GzmA], and GzmB) on cells isolated from SLE patients and healthy controls were analyzed by flow cytometry. CD107a expression and interferon-? (IFN?) production in response to viral antigenic stimulation in the presence or absence of an anti-SLAMF7 antibody were assessed by flow cytometry. Antiviral cytotoxic activity in response to SLAMF7 engagement was determined using a flow cytometry-based assay.The distribution of CD8+ T cell subsets was altered in the peripheral blood of SLE patients, with a decreased effector cell subpopulation. Memory CD8+ T cells from SLE patients displayed decreased amounts of SLAMF7, a surface receptor that characterizes effector CD8+ T cells. Ligation of SLAMF7 increased CD8+ T cell degranulation capacity and the percentage of IFN?-producing cells in response to antigen challenge in SLE patients and healthy controls. Moreover, SLAMF7 engagement promoted cytotoxic lysis of target cells in response to stimulation with viral antigens.CD8+ T cell activation in response to viral antigens is defective in SLE patients. Activation of SLAMF7 through a specific monoclonal antibody restores CD8+ T cell antiviral effector function to normal levels and thus represents a potential therapeutic option in SLE.

SUBMITTER: Comte D 

PROVIDER: S-EPMC5406259 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Signaling Lymphocytic Activation Molecule Family Member 7 Engagement Restores Defective Effector CD8+ T Cell Function in Systemic Lupus Erythematosus.

Comte Denis D   Karampetsou Maria P MP   Yoshida Nobuya N   Kis-Toth Katalin K   Kyttaris Vasileios C VC   Tsokos George C GC  

Arthritis & rheumatology (Hoboken, N.J.) 20170501 5


<h4>Objective</h4>Effector CD8+ T cell function is impaired in systemic lupus erythematosus (SLE) and is associated with a compromised ability to fight infections. Signaling lymphocytic activation molecule family member 7 (SLAMF7) engagement has been shown to enhance natural killer cell degranulation. This study was undertaken to characterize the expression and function of SLAMF7 on CD8+ T cell subsets isolated from the peripheral blood of SLE patients and healthy subjects.<h4>Methods</h4>CD8+ T  ...[more]

Similar Datasets

| S-EPMC4690788 | biostudies-literature
| S-EPMC6310084 | biostudies-literature
| S-EPMC5636110 | biostudies-literature
| S-EPMC4435497 | biostudies-literature
2014-06-03 | E-GEOD-46923 | biostudies-arrayexpress
| S-EPMC4066615 | biostudies-literature
2014-06-03 | GSE46923 | GEO
| S-EPMC3247638 | biostudies-literature
| S-EPMC3042628 | biostudies-other
| S-EPMC3303577 | biostudies-other